Surmodics | SRDX - Stock


Surmodics reported $15.17M in Stock for its fiscal quarter ending in September of 2024.





Stock Change Date
Abbott USD 6.49B 220M Dec/2025
Align Technology USD 228.16M 15.59M Sep/2025
Anika Therapeutics USD 16.28M 638K Sep/2025
Arrowhead Research USD -173.08M 173.08M Dec/2024
Artivion USD 90.55M 3.82M Sep/2025
Baxter International USD 2.23B 228M Dec/2025
Boston Scientific USD 2.94B 22M Dec/2025
EDAP TMS EUR 13.8M 1.73M Sep/2025
Edwards Lifesciences USD 1.14B 800K Sep/2025
Haemonetics USD 321.18M 15.02M Dec/2025
Heron Therapeutics USD 54.57M 2.33M Dec/2022
J&J USD 14.19B 45M Dec/2025
Merit Medical Systems USD 333.7M 7.15M Dec/2025
Mesa Laboratories USD 26.56M 1.18M Dec/2025
Nektar Therapeutics USD 14.46M 1.78M Jun/2024
Option Care Health USD 471.15M 55.43M Dec/2025
Stryker USD 5.31B 60M Dec/2025
Surmodics USD 15.17M 230K Sep/2024
Trinity Biotech USD 19.16M 210K Sep/2025